Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03869
Species: Homo sapiens
Position : chr13:28843000-28843500
Year: 2020
Title: 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: B-cell acute lymphoblastic leukemia
PMID:  32384149
MONDO: MONDO:0004947
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: NALM-6
CVCL ID: CVCL_0092
Cell Type: B-lymphoblast
Cell Ontology ID: CL:0017006
Experiment Type: Enhancer activity assay, Chromatin interaction assay
High Throughput Method: ChIP-seq, RNA-seq, Hi-C, PLAC-seq, ATAC-seq, DNase-seq
Low Throughput Method: RT-RT-qPCR, FISH
About Target Gene
Target gene : FLT3
About TF
TF name : RUNX1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
RUNX1 AndrogenReceptor netpath 167
RUNX1 Organic cation transport reactome 9
RUNX1 RANKL netpath 84
RUNX1 Regulation of nuclear SMAD2/3 signaling pid 82
RUNX1 TGF_beta_Receptor netpath 220
RUNX1 Validated transcriptional targets of deltaNp63 isoforms pid 47
RUNX1 Pathways in cancer kegg 321
RUNX1 Chronic myeloid leukemia kegg 69
RUNX1 Acute myeloid leukemia kegg 53
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_02624 chr13:28840000-28850000 blood precursor B cell KMT2A-rearranged acute lymphoblastic leukemia
E_02625 chr13:28840000-28850000 blood precursor B cell KMT2A-rearranged acute lymphoblastic leukemia
E_03831 chr13:28843000-28843500 blood B cell KMT2A::AFF1-rearranged B-cell acute lymphoblastic leukemia
E_03832 chr13:28843000-28843500 bone marrow B-lymphoblast B-cell acute lymphoblastic leukemia
E_03867 chr13:28843000-28843500 blood B cell KMT2A::AFF1-rearranged B-cell acute lymphoblastic leukemia
E_03868 chr13:28843000-28843500 blood B cell KMT2A::AFF1-rearranged B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer